Skip to main content
OpenTrials
Completed

NCT Number: NCT03448276

Immediate Effect Of Whole-Body Vibration And Walk in Osteoporosis/Osteopenia

Introduction: Osteoporosis and Osteopenia are common bone disorders, characterized by low bone mass, signs of bone deterioration and are responsible for typical bone fragility. Physical activity is certainly a valid prevention tool because it contributes to a healthy energy balance, increasing muscle mass and providing beneficial effects in bone metabolism. Stress induced by more vigorous activities such as weight lifting, increases the risk of injury, particularly in the elderly. Therefore, alternative strategies with lower risk of injury are indicated such as whole body vibration and walk.

Objective: Compare the effect whole body vibration and walking on muscular strength, balance and functional performance in the elderly with Osteoporosis and Osteopenia

Methods: It is a clinical trial study, controlled, parallel, randomized and blind, which will follow the guidelines established in the Consolidated Standards of Reporting Trials (CONSORT). Participants will be randomly distributed in 2 groups: the experimental group (GI) that will hold the training in the vibrating platform and the control group (GC) that will perform the walk, settling 1 treatment session. All participants will be subjected to the initial and final assessment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year–90 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UFPE

Recife, Pernambuco, Brazil

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Confirmed diagnosis of osteoporosis or osteopenia examination of bone densitometry;
  • Patients without severe neurological disease, vascular disorders, labyrinthitis and blindness;
  • No use of gait auxiliaries;
  • No history of fractures of the lower limbs in the last year;
  • Do not be an alcoholic inactive (0 to 5 points) or less active (6 to 11 points) accordance with the usual physical activity questionnaire (QAFH).

Exclusion criteria

-Patients who submit to hypertensive peak, nausea and dizziness during the training program.

Treatment and study plan

Training in the vibrating platform

Other

20-minute workout will be held, which will include: heating (5 minutes and stretching for the muscles quadriceps and sural triceps), 10 and 5 min of cooling.

Walk

Other

Will be held 30 minutes of training, which will include the heating (5 minutes of stretching for the muscles quadriceps and sural triceps), 10 and 5 min of cooling.

Primary outcomes

  1. Muscular strength

    Time frame: 20 minutes

    Test of 1 repetition maximum (1RM)

  2. Balance

    Time frame: 20 minutes

    Berg Balance scale (BBS). Minimum score 0 and maximum 56, the lower the score the greater the risk of falls.

  3. Functional performance

    Time frame: 20 minutes

    Timed Up and Go test (TUG)

  4. Balance

    Time frame: 20 minutes

    Stabilometry by Baropodometry

Secondary outcomes

  1. Plantar pressure distribution

    Time frame: 20 minutes

    Baropodometry

Sponsors and collaborators

Lead sponsor

Universidade Federal de Pernambuco

Other

Registry information

Official study title

Immediate Effect Of Whole-Body Vibration And Walk Over Muscle Strength, Balance And Functional Performance In Elderly People With Osteoporosis And Osteopenia: Clinical Randomized Controlled Trial

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Feb 28, 2018
Registry last updated
Oct 22, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.